SLA |
1. GelMA + PEGDA + nHA as bone phase |
hMSCs seeding after printing, in vitro differentiation |
1. Intense histological staining in the scaffolds with TGF-β1 encapsulated PLGA and nano-HAp based scaffolds (GelMA—PEGDA—nHAp/TGF-β1 PLGA NPs) |
[139] |
2. GelMA+PEGDA+TGF-β1 encapsulated PLGA as chondral phase |
2. Higher expression levels of collagen II, SOX-9 and aggrecan in the cartilage layer |
Microextrusion |
1. PCL/HAp as bone phase printing followed by hMSCs and HUVECs laden GelMA |
hMSCs in both phases. Osteogenic and chondrogenic media flow in dual chamber bioreactor |
1. In vitro vascularization |
[140] |
2. Endothelial cells enhanced osteogenic differentiation of hMSCs |
2. hMSCs laden GelMA as cartilage layer |
3. A higher expression of collagen I and OPN as well as alizarin red staining |
4. collagen II, SOX9 and aggrecan upregulation and intense staining of alcian blue in the chondral region |
3D plotting |
1. Alginic acid sodium salt and methyl-cellulose (algMC) as cartilage phase |
— |
1. Defect specific multi-zonal reconstruction of osteochondral lesion using advanced MRI data from patients |
[141] |
2. Calcium phosphate cement (CPC) as bone phase |
2. High clinical implication: osteochondral lesions and defects are patient-specific and should be treated personalized manner |
FDM |
1. 3D printed networks of PLA, PLGA and PCL fibers with (MSCs) laden alginate hydrogel as bone phase |
MSCs, FPSCs and chondrocytes seeding during manufacturing. |
1. Vascularised bone formation along with phenotypically stable cartilage formed on the surface, subcutaneously in mice model |
[143] |
2. Same fibers with FPSCs and chondrocytes laden hydrogel on cartilage layer |
2. Superior hyaline cartilage formation in caprine femoral condyle while compared with commercial control |
Microextrusion |
Gradient porous PCL-PLGA fiber network. Higher porous cartilage side: CS modified PCL and lower porous bone side: β-TCP modified PLGA fibers |
Post-printing culture with adipose-derived MSCs (ADMSCs) |
1. Higher amount of sGAG in the cartilage layer of PCL/PLGA/CS scaffolds along with increased expression level of collagen II, SOX9 and aggrecan when compared to PCL/PLGA scaffolds. |
[144] |
2. PCL/PLGA/βTCP bone region of the osteochondral scaffolds also exhibited enhanced ALP activity and mineralization when compared to the control counterpart |
SLA |
1. 20% n-HAp as bone phase |
hMSCs post-printing seeding in vitro
|
1. Highly interconnected porosity with nano-to-micro structure and spatiotemporal growth factor gradients |
[145] |
2. 10% n-HAp as an intermediate phase |
2. TGF-β1 encapsulated PLGA scaffold outperformed all control samples in GAG deposition |
3. TGF-β1 encapsulated PLGA as cartilage phase |
3. Osteochondral scaffold with nHA and TGF-β1 showed the highest mineral deposition in the bone phase |
Microextrusion |
1. 15% GelMA hydrogel for cartilage zone |
BMSCs seeding and in vivo implantation in rabbit osteochondral model |
1. H&E staining shows a clear tidemark in the neo-tissue in the tri-layered scaffold group |
[146] |
2. 20% GelMA and 3% n-HAp as intermediate zone |
2. From gross-morphology, the tri-layered scaffold surpassed other groups in cartilage regeneration |
3. 30% GelMA and 3% n-HAp as bone zone |
3. The most intense orange color in the Safranin-O stained tri-layered scaffold demonstrates enhanced cartilage regeneration, in vivo
|
Digital light processing (DLP) |
Monophasic radially oriented osteochondral scaffold with GelMA, MSCs exosomes and cartilage-derived ECM |
In vivo implantation in rabbit femoral condyle |
1. Complete healing of cartilage from gross morphology analysis. Higher GAG deposition |
[142] |
2. Enhanced subchondral ossification: higher ratio of bone volume to tissue volume (BV/TV) and trabecular thickness in the ECM/GelMA/exosome scaffolds |